Bright Minds Biosciences Inc. (DRUG)
Market Closed
17 Jul, 20:00
$
76. 12
+1.89
+2.5461%
$
604.16M Market Cap
- P/E Ratio
- Div Yield
157,400 Volume
0 Eps
$ 74.23
Previous Close 
Want to track DRUG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bright Minds Biosciences Inc. (DRUG) Statistics
Valuation metrics
Market Cap 604.16M
Enterprise value 528.35M
Trailing P/E (ttm) -31.8
Forward P/E -
PEG ratio 0.29
Price/Sales (ttm) -
Price/Book (mrq) 3.36
Enterprise Value/Revenue -
Enterprise Value/EBITDA -16.87
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 188.02K
Average volume (90 days) 262.82K
Price summary
52-Week low 24.61
52-Week high 123.75
Beta -
50-Day moving average 68.23
200-Day moving average 81.09
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 14 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.09%
Return on equity -0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.87
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 32.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 81.48%
Book value per share (mrq) 32.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
